Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.

Hayes MJ, Prasad V.

Hastings Cent Rep. 2018 Mar;48(2):10-13. doi: 10.1002/hast.833.

PMID:
29590518
2.

Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes.

Hayes MJ, Kaestner V, Mailankody S, Prasad V.

CMAJ Open. 2018 Jan 15;6(1):E31-E38. doi: 10.9778/cmajo.20170088.

3.
4.

Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.

Arhancet GB, Walker DP, Metz S, Fobian YM, Heasley SE, Carter JS, Springer JR, Jones DE, Hayes MJ, Shaffer AF, Jerome GM, Baratta MT, Zweifel B, Moore WM, Masferrer JL, Vazquez ML.

Bioorg Med Chem Lett. 2013 Feb 15;23(4):1114-9. doi: 10.1016/j.bmcl.2012.11.109. Epub 2012 Dec 6.

PMID:
23260349
5.

Summary of the Eleventh Annual University of Wisconsin Land O'Lakes Bioanalytical Conference.

Demuth JE, Hayes MJ, Amaravadi L, Arnold ME, Briscoe C, Clement RP, Ho S, Ji QC, Turk DJ.

Bioanalysis. 2010 Oct;2(10):1677-81. doi: 10.4155/bio.10.141. No abstract available.

6.

Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment.

Rose CM, Hayes MJ, Stettler GR, Hickey SF, Axelrod TM, Giustini NP, Suljak SW.

Analyst. 2010 Nov;135(11):2945-51. doi: 10.1039/c0an00445f. Epub 2010 Sep 6.

7.

Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.

Hayes MJ, Thomas D, Emmons A, Giordano TJ, Kleer CG.

Clin Cancer Res. 2008 Jul 1;14(13):4038-44. doi: 10.1158/1078-0432.CCR-07-4379.

8.

Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.

Ramanathan RK, Egorin MJ, Takimoto CH, Remick SC, Doroshow JH, LoRusso PA, Mulkerin DL, Grem JL, Hamilton A, Murgo AJ, Potter DM, Belani CP, Hayes MJ, Peng B, Ivy SP; National Cancer Institute Organ Dysfunction Working Group.

J Clin Oncol. 2008 Feb 1;26(4):563-9. doi: 10.1200/JCO.2007.11.0304.

PMID:
18235115
9.

First-receiver hospital decontamination: an 8-step approach to a progressive and practical program.

Edwards D, Williams LH, Beatty J, Hayes MJ, Conner BB, Hodgson MJ, Scott MA.

J Nurs Adm. 2007 Mar;37(3):122-30.

PMID:
17496776
10.

Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.

Hayes MJ, Carey JL, Krauss JC, Hedstrom DL, Gulbranson RL, Keren DF.

Eur J Haematol. 2007 Apr;78(4):353-7.

11.

Biliary excretion of imatinib mesylate and its metabolite CGP 74588 in humans.

Ramalingam S, Lagattuta TF, Egorin MJ, Hayes MJ, Ramanathan RK.

Pharmacotherapy. 2004 Sep;24(9):1232-5.

PMID:
15460185
12.

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.

Peng B, Dutreix C, Mehring G, Hayes MJ, Ben-Am M, Seiberling M, Pokorny R, Capdeville R, Lloyd P.

J Clin Pharmacol. 2004 Feb;44(2):158-62.

PMID:
14747424
14.

Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.

Parlow JJ, Case BL, Dice TA, Fenton RL, Hayes MJ, Jones DE, Neumann WL, Wood RS, Lachance RM, Girard TJ, Nicholson NS, Clare M, Stegeman RA, Stevens AM, Stallings WC, Kurumbail RG, South MS.

J Med Chem. 2003 Sep 11;46(19):4050-62.

PMID:
12954058
15.

Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.

South MS, Case BL, Wood RS, Jones DE, Hayes MJ, Girard TJ, Lachance RM, Nicholson NS, Clare M, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, Parlow JJ.

Bioorg Med Chem Lett. 2003 Jul 21;13(14):2319-25.

PMID:
12824026
16.

Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.

Parise RA, Ramanathan RK, Hayes MJ, Egorin MJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):39-44.

PMID:
12798163
17.

Conjugated macrocycles related to the porphyrins. 21. Synthesis, spectroscopy, electrochemistry, and structural characterization of carbaporphyrins.

Lash TD, Hayes MJ, Spence JD, Muckey MA, Ferrence GM, Szczepura LF.

J Org Chem. 2002 Jul 12;67(14):4860-74.

PMID:
12098299

Supplemental Content

Loading ...
Support Center